Trials / Completed
CompletedNCT02768155
Evaluation of Amniotic Fluid Product in Knee Osteoarthritis
Protocol for the Clinical Evaluation Amniotic Fluid (AF) Product in Knee Osteoarthritis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- MiMedx Group, Inc. · Industry
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
A study evaluating Amniotic Fluid compared to a Saline Placebo Injection in the treatment of subjects with osteoarthritic (OA) knee pain
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Amniotic Fluid 4.0ml dose | Injection of Amniotic Fluid |
| OTHER | Amniotic Fluid 2.0ml dose | Injection of Amniotic Fluid |
| OTHER | Placebo Control | Normal Saline |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2017-04-01
- Completion
- 2017-07-01
- First posted
- 2016-05-11
- Last updated
- 2017-10-26
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02768155. Inclusion in this directory is not an endorsement.